.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Natural products remain indispensable for modern medicine and human nutrition. Therefore, researchers continuously seek more effective ways to profile plant metabolites. Phytometabolomics has recently gained significant momentum due to rapid improvements in mass spectrometry. However, traditional organic solvents often pose safety and efficiency challenges. Consequently, scientists are adopting NADES green extraction media to enhance the recovery and stability of natural compounds.
These natural solvents consist of simple metabolites such as sugars, amino acids, and organic acids. Moreover, they offer a tunable composition that allows researchers to target specific bioactives. Scientists prefer these solvents because they are biodegradable and exhibit low toxicity. Furthermore, they stabilize labile compounds better than conventional organic solvents. Consequently, they provide a promising strategy for sustainable pharmaceutical and food research. In addition, the use of these green media aligns with global efforts to reduce chemical waste in laboratories.
Despite these clear benefits, some technical limitations exist. Specifically, high viscosity can occasionally hinder large-scale industrial application. Additionally, the standardization of NADES compositions remains a primary concern for regulatory compliance. However, ongoing studies aim to optimize these green solvents for wider clinical and industrial use in India and abroad.
Natural Deep Eutectic Solvents typically consist of natural metabolites such as sugars, amino acids, and organic acids. These components interact to create a liquid phase with unique extraction properties.
These solvents form strong hydrogen bonds with plant metabolites. Therefore, they protect sensitive compounds from thermal or chemical degradation during the extraction process.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Singh IP et al. Natural Deep Eutectic Solvents as Green Extraction Media for Nutritional and Functional Bioactives. J Agric Food Chem. 2026 May 06. doi: 10.1021/acs.jafc.6c00066. PMID: 42090186.
Shikov AN et al. Natural Deep Eutectic Solvents: Green Chemistry Solutions for Pharmaceutical Applications. Molecules. 2020;25(7):1619.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NADES offer a sustainable and efficient alternative to traditional solvents for extracting plant bioactives, enhancing stability and reducing toxicity....
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
